Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Top Cited Papers
- 25 November 2011
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 334 (6059), 1129-1133
- https://doi.org/10.1126/science.1206727
Abstract
The mitochondrial state of a tumor cell prior to chemotherapy may help determine how well it responds to drug treatment.Keywords
This publication has 36 references indexed in Scilit:
- Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+CD8+thymocytesProceedings of the National Academy of Sciences of the United States of America, 2010
- The BCL-2 Family ReunionMolecular Cell, 2010
- Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myelomaBlood, 2010
- Apoptosis and non-inflammatory phagocytosis can be induced by mitochondrial damage without caspasesCell Death & Differentiation, 2009
- MCL-1–dependent leukemia cells are more sensitive to chemotherapy than BCL-2–dependent counterpartsThe Journal of cell biology, 2009
- Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737JCI Insight, 2007
- Predictive factors for response to docetaxel in human breast cancersCancer Science, 2006
- Cell Death: Critical Control PointsCell, 2004
- The role of p53 in determining sensitivity to radiotherapyNature Reviews Cancer, 2003
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001